Brookhaven Hospital: Mental Health Treatment for Behavioral Health Problems, Chemical Dependency, Eating Disorders, Brain Injuries, and Renewal Christian Treatment and Recovery

Monday, July 24, 2006 1:29 PM
posted by R. Shock

FDA Warns Against Taking Antidepressants with Migraine Drugs

The federal Food and Drug Administration has issued a public health advisory warning not to take certain types of antidepressant drugs in conjunction with certain types of drugs for treatment of migraine headaches. According to the FDA advisory, mixing the drugs can trigger serotonin-syndrome, a serious, life-threatening condition.

Serotonin-syndrome is characterized by rapid heart beat, sudden changes in blood pressure, and increased body temperature. Other symptoms include restlessness, hallucinations, loss of coordination, overactive reflexes, nausea, vomiting, and diarrhea.

The FDA has strongly advised that anyone who experiences these symptoms when taking these drugs should seek immediate medical treatment.

Click here for the full article, courtesy of MedPageToday.com
link to this post

Rolf B. Gainer, Ph.D., Diplomate ABDA, is the Chief Executive Office at Brookhaven Hospital and the Vice President of Rehabilitation Institutes of America. Dr. Gainer has been involved in the design and operation of treatment programs since 1977.

Stephen Harnish, MD is the Medical Director of Brookhaven Hospital. Dr. Harnish is a member of the American Psychiatric Association and is well known in Oklahoma for his informative radio and television appearances.

Aric Thorpe, MHR, is Brookhaven Hospital's Pastoral Liaison Representative. He conducts the quarterly Minister's Lifeline series and provides mental health information to pastors and clergy.

Sarah McGee serves as the Community Education Provider for Brookhaven Hospital. She provides information on mental health and drug and alcohol treatment to healthcare professionals in Oklahoma and surrounding states.

| Outpatient Services |